By testing the antibody amounts required to reduce viral loads in middle east respiratory syndrome (MERS) infected mice, researchers were able to estimate how much antibody serum a person would need to fight MERS.
Since the December 2016 update, 31 percent of Middle East respiratory syndrome (MERS) cases reported to the World Health Organization (WHO) were associated with healthcare facility transmission.
Researchers summarize the epidemiological, clinical, and laboratory findings of the first Korean case of MERS-CoV.
Since July 2012, 1,677 patients have been infected by middle east respiratory syndrome (MERS) in Saudi Arabia.
The patient was diagnosed, on June 16, 2017, after returning from Saudi Arabia.
This course on Middle East respiratory syndrome (MERS) is intended for incident managers and personnel working for the United nations, international organizations and NGOs.
To date, there has been no effective antiviral drug for any known coronavirus.
Forty-two patients are under treatment.
Middle East respiratory syndrome (MERS) can spread quickly in the hospital setting.
The cluster has generated over three dozen cases since the beginning of June.